ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP · NASDAQ Global Market
+$0.44 today
Vol 0.59M · Avg 0.50M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+39.21%
Period High
$33.09
Period Low
$16.95
Latest
$31.74
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Erasca, Inc.
NASDAQ:ERAS
$4.32B
Day One Biopharmaceuticals, Inc.
DAWN
$2.22B
Iovance Biotherapeutics, Inc.
NASDAQ:IOVA
$1.40B
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX
$1.38B
MeiraGTx Holdings plc
NASDAQ:MGTX
$1.02B
Replimune Group, Inc.
NASDAQ:REPL
$829.03M
Astria Therapeutics, Inc.
ATXS
$718.13M
Ginkgo Bioworks Holdings, Inc.
NYSE:DNA
$583.02M
Valneva SE
NASDAQ:VALN
$511.10M
Arvinas, Inc.
NASDAQ:ARVN
$488.43M
What is the latest AVBP filing?
The latest filing shown is 8-K dated May 11, 2026.
How many recent filings does AVBP have?
Intrinsic Alpha currently shows 20 recent filings for AVBP.
Explore More
Continue the stock analysis
Jump to another research area for this company.